PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-04

Date Title Company
04-Sep-2024 Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump AccessWire
04-Sep-2024 Unlock the "Craving Reset Code" and Break Free from Nicotine Addiction - The Revolutionary Holistic Approach to Quitting for Good AccessWire
04-Sep-2024 Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump AccessWire
04-Sep-2024 U.S. Physicians Overwhelmingly Support Current FDA Data Standards, Switching Studies for Interchangeable Biosimilars; Oppose Pharmacy Substitution of Non-Interchangeable Biosimilars Newswire
04-Sep-2024 Wisdom Teeth Management: Modern Approaches to Extraction and Prevention in Cumming AccessWire
04-Sep-2024 Innovation Passport Award CRISM Therapeutics Corporation
04-Sep-2024 MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year MeVis Medical Solutions AG
04-Sep-2024 Tenon Medical Announces 1:8 Reverse Split AccessWire
04-Sep-2024 WHO’s mpox response plan provides direction for coordinated response to reduce disease burden, says GlobalData World Health Organization (WHO)
04-Sep-2024 Adults in England and Wales with rare blood disorder to get access to new oral monotherapy on NHS Novartis
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 Phesi wins Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with its Trial Accelerator Platform Phesi
04-Sep-2024 Kosten Digital Launches in the U.S. to Transform Life Sciences with Custom AI Solutions, Welcomes Industry Leader Amy DuRoss to Advisory Board Kosten Digital
04-Sep-2024 Russell Abberley, Amgen UK & Ireland, steps up as Acting ABPI President Association of the British Pharmaceutical Industry (ABPI)
04-Sep-2024 MHRA licenses first in new class of treatment for patients with endometriosis symptoms in the UK Gedeon Richter UK Ltd
04-Sep-2024 Envirotainer completes integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain Envirotainer
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board PulseSight Therapeutics SAS
04-Sep-2024 Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Actimed Therapeutics
04-Sep-2024 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock Medidata